Regulation of matrix metalloproteinases 2 and 9 activities by peroxynitrites in term placentas from type 2 diabetic patients

Reproductive Sciences

Volumn 19, Issue 8, 2012, Pages 814-822

  Capobianco, Evangelina ^a   White, Verónica ^a   Sosa, María ^a   Marco, Ingrid Di ^b   Basualdo, María Natalia ^b   Faingold, María Cristina ^c   Jawerbaum, Alicia ^a  

^a Centre de Estudios Farmacologicos y Botanicos   (Argentina)

^b Hospital Materno Infantil Ramon Sarda   (Argentina)

^c Unidad Asistencial Dr César Milstein   (Argentina)

Author keywords

diabetes; matrix metalloproteinases (MMPs); peroxynitrites; placenta; pregnancy

Indexed keywords

GELATINASE A; GELATINASE B; NITRIC OXIDE; PEROXYNITRITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADULT; ARTICLE; CHORION VILLUS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; HUMAN; HUMAN TISSUE; LIPID PEROXIDATION; NITRATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLACENTA; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEIN NITRATION; TISSUE LEVEL; WESTERN BLOTTING; ZYMOGRAPHY;

ADULT; DIABETES MELLITUS, TYPE 1; ENZYME ACTIVATION; FEMALE; HUMANS; LIPID PEROXIDATION; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; NITRATES; NITRIC OXIDE; PEROXYNITROUS ACID; PLACENTA; PREGNANCY; PREGNANCY IN DIABETICS; TISSUE CULTURE TECHNIQUES;

EID: 84864363685     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719111434544     Document Type: Article

References (48)

1. Balsells M, Garcia-Patterson A, Gich I, Corcoy R. Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and metaanalysis. J Clin Endocrinol Metab. 2009 ; 94 (11). 4284-4291
2. Michael Weindling A. Offspring of diabetic pregnancy: short-term outcomes. Semin Fetal Neonatal Med. 2009 ; 14 (2). 111-118
3. Melamed N, Hod M. Perinatal mortality in pregestational diabetes. Int J Gynaecol Obstet. 2009 ; 104 (suppl 1). S20 - S24
4. Plagemann A, Harder T, Dudenhausen JW. The diabetic pregnancy, macrosomia, and perinatal nutritional programming. Nestle Nutr Workshop Ser Pediatr Program. 2008 ; 61: 91-102
5. Thornburg KL, O'Tierney P, Louey S. The placenta is a programming agent in cardiovascular disease. Placenta. 2010 ; 31 (suppl). 54-59
6. Jansson T, Myatt L, Powell TL. The role of trophoblast nutrient and ion transporters in the development of pregnancy complications and adult disease. Curr Vasc Pharmacol. 2009 ; 7 (4). 521-533
7. Omu AE, Al-Azemi MK, Omu FE, et al. Butyrylcholinesterase activity in women with diabetes mellitus in pregnancy: correlation with antioxidant activity. J Obstet Gynaecol. 2010 ; 30 (2). 122-126
8. Pacher P, Obrosova IG, Mabley JG, Szabo C.. Role of nitrosative stress and peroxynitrite in the pathogenesis of diabetic complications. Emerging new therapeutical strategies. Curr Med Chem. 2005 ; 12 (3). 267-275 (Pubitemid 40305619)
9. Lyall F, Gibson JL, Greer IA, Brockman DE, Eis AL, Myatt L. Increased nitrotyrosine in the diabetic placenta: evidence for oxidative stress. Diabetes Care. 1998 ; 21 (10). 1753-1758 (Pubitemid 28449820)
10. Horvath EM, Magenheim R, Kugler E, et al. Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies. Diabetologia. 2009 ; 52 (9). 1935-1943
11. San Martin R, Sobrevia L. Gestational diabetes and the adenosine/L-arginine/nitric oxide (ALANO) pathway in human umbilical vein endothelium. Placenta. 2006 ; 27 (1). 1-10 (Pubitemid 41662874)
12. Lappas M, Hiden U, Froehlich J, Desoye G, Haugel-De Mouzon S, Jawerbaum A. The role of oxidative stress in the pathophysiology of gestational diabetes mellitus. Antioxid Redox Signal. 2011 ; 15 (12). 3061-3100
13. Pustovrh MC, Jawerbaum A, Capobianco E, et al. Oxidative stress promotes the increase of matrix metalloproteinases-2 and -9 activities in the feto-placental unit of diabetic rats. Free Radic Res. 2005 ; 39 (12). 1285-1293 (Pubitemid 43023793)
14. Pustovrh C, Jawerbaum A, Sinner D, et al. Membrane-type matrix metalloproteinase-9 activity in placental tissue from patients with pre-existing and gestational diabetes mellitus. Reprod Fertil Dev. 2000 ; 12 (5-6). 269-275 (Pubitemid 32514756)
15. Vu TH, Werb Z. Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev. 2000 ; 14 (17). 2123-2133
16. Huang SC, Sheu BC, Chang WC, Cheng CY, Wang PH, Lin S. Extracellular matrix proteases-cytokine regulation role in cancer and pregnancy. Front Biosci. 2009 ; 14: 1571-1588
17. Cockle JV, Gopichandran N, Walker JJ, Levene MI, Orsi NM. Matrix metalloproteinases and their tissue inhibitors in preterm perinatal complications. Reprod Sci. 2007 ; 14 (7). 629-645 (Pubitemid 351903568)
18. Cohen M, Bischof P. Factors regulating trophoblast invasion. Gynecol Obstet Invest. 2007 ; 64 (3). 126-130 (Pubitemid 47574869)
19. Valdes G, Corthorn J. Review: the angiogenic and vasodilatory utero-placental network. Placenta. 2011 ; 32 (suppl 2). S170 - S175
20. Wang W, Sawicki G, Schulz R. Peroxynitrite-induced myocardial injury is mediated through matrix metalloproteinase-2. Cardiovasc Res. 2002 ; 53 (1). 165-174 (Pubitemid 34020777)
21. Gu Z, Kaul M, Yan B, et al. S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death. Science. 2002 ; 297 (5584). 1186-1190 (Pubitemid 36193354)
22. Harris LK, Mccormick J, Cartwright JE, Whitley GS, Dash PR. S-nitrosylation of proteins at the leading edge of migrating trophoblasts by inducible nitric oxide synthase promotes trophoblast invasion. Exp Cell Res. 2008 ; 314 (8). 1765-1776
23. Mandal M, Mandal A, Das S, Chakraborti T, Sajal C. Clinical implications of matrix metalloproteinases. Mol Cell Biochem. 2003 ; 252 (1-2). 305-329 (Pubitemid 37220762)
24. Derosa G, D'angelo A, Tinelli C, et al. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects. Diabetes Metab. 2007 ; 33 (2). 129-134
25. Thrailkill KM, Bunn RC, Moreau CS, et al. Matrix metalloproteinase-2 dysregulation in type 1 diabetes. Diabetes Care. 2007 ; 30 (9). 2321-2326 (Pubitemid 47359041)
26. Pustovrh MC, Jawerbaum A, Capobianco E, White V, Lopez-Costa JJ, Gonzalez E. Increased matrix metalloproteinases 2 and 9 in placenta of diabetic rats at midgestation. Placenta. 2005 ; 26 (4). 339-348 (Pubitemid 40485871)
27. Pustovrh C, Jawerbaum A, Sinner D, White V, Capobianco E, Gonzalez E. Metalloproteinase 2 activity and modulation in uterus from neonatal streptozotocin-induced diabetic rats during embryo implantation. Reprod Fertil Dev. 2002 ; 14 (7-8). 479-485 (Pubitemid 36231131)
28. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 ; 72: 248-254
29. White V, Capobianco E, Higa R, et al. Increased nitration and diminished activity of copper/zinc superoxide dismutase in placentas from diabetic rats. Free Radic Res. 2010 ; 44 (12). 1407-1415
30. Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol. 2007 ; 26 (8). 587-596 (Pubitemid 350180394)
31. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979 ; 95 (2). 351-358 (Pubitemid 9194347)
32. Szabo C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett. 2003 ;: 140 105-141 112
33. Pustovrh MC, Jawerbaum A, White V, et al. The role of nitric oxide on matrix metalloproteinase 2 (MMP2) and MMP9 in placenta and fetus from diabetic rats. Reproduction. 2007 ; 134 (4). 605-613 (Pubitemid 47555054)
34. Macmillan-Crow LA, Thompson JA. Immunoprecipitation of nitrotyrosine-containing proteins. Methods Enzymol. 1999 ; 301: 135-145 (Pubitemid 28489774)
35. Jawerbaum A, White V. Animal models in diabetes and pregnancy. Endocr Rev. 2010 ; 31 (5). 680-701
36. Jawerbaum A, Gonzalez E. Diabetic pregnancies: the challenge of developing in a pro-inflammatory environment. Curr Med Chem. 2006 ; 13 (18). 2127-2138 (Pubitemid 44132605)
37. Mott JD, Werb Z. Regulation of matrix biology by matrix metalloproteinases. Curr Opin Cell Biol. 2004 ; 16 (5). 558-564 (Pubitemid 39201241)
38. Dean RA, Overall CM. Proteomics discovery of metalloproteinase substrates in the cellular context by iTRAQ labeling reveals a diverse MMP-2 substrate degradome. Mol Cell Proteomics. 2007 ; 6 (4). 611-623 (Pubitemid 46630094)
39. Demir-Weusten AY, Seval Y, Kaufmann P, Demir R, Yucel G, Huppertz B. Matrix metalloproteinases-2, -3 and -9 in human term placenta. Acta Histochem. 2007 ; 109 (5). 403-412 (Pubitemid 47488477)
40. Weiss A, Goldman S, Shalev E. The matrix metalloproteinases (MMPS) in the decidua and fetal membranes. Front Biosci. 2007 ; 12: 649-659 (Pubitemid 46860207)
41. Schulz R. Intracellular targets of matrix metalloproteinase-2 in cardiac disease: rationale and therapeutic approaches. Annu Rev Pharmacol Toxicol. 2007 ; 47: 211-242
42. Freise C, Erben U, Muche M, et al. The alpha 2 chain of collagen type VI sequesters latent proforms of matrix-metalloproteinases and modulates their activation and activity. Matrix Biol. 2009 ; 28 (8). 480-489
43. Baker AH, Edwards DR, Murphy G. Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002 ; 115 (pt 9). 3719-3727 (Pubitemid 35203598)
44. Nelson KK, Melendez JA. Mitochondrial redox control of matrix metalloproteinases. Free Radic Biol Med. 2004 ; 37 (6). 768-784 (Pubitemid 39078549)
45. Hu J, Van Den Steen PE, Sang QX, Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat Rev Drug Discov. 2007 ; 6 (6). 480-498 (Pubitemid 47064570)
46. Manicone AM, Mcguire JK. Matrix metalloproteinases as modulators of inflammation. Semin Cell Dev Biol. 2008 ; 19 (1). 34-41 (Pubitemid 350235986)
47. Webster RP, Roberts VH, Myatt L. Protein nitration in placenta-functional significance. Placenta. 2008 ; 29 (12). 985-994
48. Webster RP, Brockman D, Myatt L. Nitration of p38 MAPK in the placenta: association of nitration with reduced catalytic activity of p38 MAPK in pre-eclampsia. Mol Hum Reprod. 2006 ; 12 (11). 677-685 (Pubitemid 44605600)